The evolving disease burden of lung cancer (2014–2023) in Qingdao, China: An observational trend study with projections

Long-term trend studies on the burden of lung cancer in Qingdao, a coastal city in China, remain limited. Therefore, this study aimed to assess temporal trends in the burden of lung cancer over 10 years and to project future patterns through 2028. Based on lung cancer incidence and mortality data obtained from the Qingdao Center for Disease Control and Prevention for the period 2014 to 2023, we calculated the age-standardized incidence rates by world standard population (ASIRW), age-standardized mortality rates by world standard population (ASMRW), and age-standardized years of life lost rates by world standard population (ASYRW) per 1,00,000 population. Temporal trends were assessed through Joinpoint regression analysis to estimate average annual percentage changes (AAPC). The GM (1,1) model was used for exploratory forecasting of lung cancer burden trends. In Qingdao, a statistically significant increasing trend was observed for ASIRW in females, with an AAPC of 3.48% (95% CI: 0.97 to 6.30, P = .004). The overall trend of ASMRW decreased with the AAPC of -2.11% (95% CI: -2.70 to -1.54, P < .001). Similarly, the ASMRW exhibited statistically significant declining trends in both males and females, with the AAPC of -1.59% (95% CI: -2.43 to -0.78, P < .001) and -2.92% (95% CI: -4.26 to -1.64, P < .001), respectively. The ASYRW showed trends consistent with that of ASMRW. Exploratory projections to 2028 indicated that the ASIRW, ASMRW, and ASYRW will generally decline, except for the ASIRW in females. These findings underscore the need for targeted interventions focusing on high-risk populations, particularly specific subgroups of women, while providing descriptive epidemiological evidence to inform future public health surveillance.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-05-22
DOI
https://doi.org/10.1097/md.0000000000049006
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The evolving disease burden of lung cancer (2014–2023) in Qingdao, China: An observational trend study with projections

Yili Wu, Zicheng Jin, F F Li, Hua Zhang et al.
Medicine
Global Cancer Incidence and Screening
article

The evolving disease burden of lung cancer (2014–2023) in Qingdao, China: An observational trend study with projections

Yili Wu, Zicheng Jin, F F Li, Hua Zhang, Haiping Duan, Yuanyuan Zhao, Ke Li, Yige Bai, Xiaojia Xue
article en

Abstract

Long-term trend studies on the burden of lung cancer in Qingdao, a coastal city in China, remain limited. Therefore, this study aimed to assess temporal trends in the burden of lung cancer over 10 years and to project future patterns through 2028. Based on lung cancer incidence and mortality data obtained from the Qingdao Center for Disease Control and Prevention for the period 2014 to 2023, we calculated the age-standardized incidence rates by world standard population (ASIRW), age-standardized mortality rates by world standard population (ASMRW), and age-standardized years of life lost rates by world standard population (ASYRW) per 1,00,000 population. Temporal trends were assessed through Joinpoint regression analysis to estimate average annual percentage changes (AAPC). The GM (1,1) model was used for exploratory forecasting of lung cancer burden trends. In Qingdao, a statistically significant increasing trend was observed for ASIRW in females, with an AAPC of 3.48% (95% CI: 0.97 to 6.30, P = .004). The overall trend of ASMRW decreased with the AAPC of -2.11% (95% CI: -2.70 to -1.54, P < .001). Similarly, the ASMRW exhibited statistically significant declining trends in both males and females, with the AAPC of -1.59% (95% CI: -2.43 to -0.78, P < .001) and -2.92% (95% CI: -4.26 to -1.64, P < .001), respectively. The ASYRW showed trends consistent with that of ASMRW. Exploratory projections to 2028 indicated that the ASIRW, ASMRW, and ASYRW will generally decline, except for the ASIRW in females. These findings underscore the need for targeted interventions focusing on high-risk populations, particularly specific subgroups of women, while providing descriptive epidemiological evidence to inform future public health surveillance.

MedicineVol. 105(21)
Qingdao University (CN), Qingdao Municipal Center for Disease Control and Prevention (CN)
Good health and well-being
Openalex Percentile: Top 7%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.